SCHEMBL18302011

SCHEMBL18302011

COC(=O)c1ccccc1-c1ccc(Br)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.56
SLC6A4 P31645 3/20 0.50
SLC6A2 P23975 1/20 0.48
TSHR P16473 2/20 0.47
LMNA P02545 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CFTR P13569 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HTT P42858 2/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA5A P35218 1/20 0.45
CA9 Q16790 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
KDM4E B2RXH2 2/20 0.45
POLB P06746 1/20 0.45
ATM Q13315 1/20 0.45
NR4A2 P43354 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25523280 0.94 SLC6A3 (0.56) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL5072166 0.90 SLC6A3 (0.59) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL18539206 0.86 SLC6A3 (0.59) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL16219703 0.85 SLC6A3 (0.49) SLC6A3SLC6A4LMNAALDH1A1KMT2A
SCHEMBL28454296 0.83 TSHR (0.57) TSHRALDH1A1HSD17B10KMT2ARXFP1
SCHEMBL15525214 0.83 SLC6A3 (0.63) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL869550 0.83 BRD4 (0.50) SLC6A3TSHRLMNAALDH1A1CFTR
SCHEMBL69464 0.82 SLC6A3 (0.67) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL18352308 0.81 PLK1 (0.54) SLC6A3SLC6A4SLC6A2TSHRLMNA
SCHEMBL13324417 0.81 SLC6A3 (0.50) SLC6A3SLC6A4SLC6A2TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107787314-B Compound for organic electric element, organic electric element using same, and electronic device using same 德山新勒克斯有限公司 2020-06-02 CN disclosed
US-10573820-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-02-25 US disclosed
US-20180182972-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-06-28 US disclosed
US-20180182972-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-06-28 US disclosed
CN-107787314-A Organic electric element compound, organic electric element and its electronic installation using it 德山新勒克斯有限公司 2018-03-09 CN disclosed
WO-2016200070-A2 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE USING SAME 덕산네오룩스 주식회사 2016-12-15 WO disclosed
WO-2016200070-A2 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE USING SAME 덕산네오룩스 주식회사 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182972-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 SLC6A3 4653/4885SLC6A4 4462/4885SLC6A2 4414/4885
US-10573820-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, LEF1 SLC6A3 4653/4885SLC6A4 4462/4885SLC6A2 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.